David W. Martin, Jr., M.D., is chairman and CEO of AvidBiotics Corporation, a biotechnology company in San Francisco. He was a founder and CEO of Eos Biotechnology, which merged with Protein Design Labs in April 2003. Previously, he has been senior vice-president of R&D at Genentech (1982-1990), executive vice-president of R&D at DuPont Merck (1991-1993), and president of Chiron Therapeutics (1994-1995). He currently serves as lead director of the boards of Varian Medical Systems, Inc., in Palo Alto, and Cubist Pharmaceuticals, Inc., in Lexington, Massachusetts, and he is a member of the executive committee of BayBio. Prior to joining Genentech in 1982, he was professor of medicine and biochemistry at the University of California, San Francisco and investigator, Howard Hughes Medical Institute. He attended the Massachusetts Institute of Technology, and received his M.D. from Duke University.

---